Nevertheless, some studies relate its expression- and methylation-level to prostate cancer [45, 46], indicating CACNA1D as a possible regulator of prostate cancer aggressiveness [47], or refer it to CNS disorders [48], diabetes [49] or calcium level within the vessels [50]. Here, CACNA1D is linked to central nervous system disorder.